Barely Significant

Excerpts

514,629 sentences

highly significantp < 0.0010.0× alphaqualifiedgold
In 53 (62.4%) of 85 knees with mild to moderate OA on AP-radiographs (K/L-score ≤ 3), the lateral femorotibial minJSW on the PA-flexed view (2.0 mm, SD 1.1) decreased highly significant ( p < 0.001) compared to the AP view (0.1 mm) and resulted in an increased K/L-score of 4 (Fig. 1 ).
marginally significantp < .0010.0× alphagold
Finally, the model on the VAS-11 yielded both a significant main effect of Time – with scores being overall lower at T1 ( M = 1.22, SE = 0.44) when compared to T0 ( M = 3.61, SE = 0.44) net of Group ; however, when exploratively assessing a marginally significant Time * Group interaction term (Fig. 2 ), post-hoc comparisons revealed that such a decrease in scores was actually significant ( p < .001) only for hyperhidrosis patients (T0: M = 4.67, SE = 0.65; T1: M = 1.44, SE = 0.65) and not for dystonia ones ( p = .110).
Does botulinum toxin affect psycho-social aspects in dystonia?
J Neural Transm (Vienna) · 2024 · PMC11343871
a decreasing trendp -value < 0.0010.0× alphagold
Thus, there was a decreasing trend in the number of CLCC posts over time (slope = −31.6; intercept = 6030.0; p -value < 0.001), with notable small spikes around 20 April (or “4/20” in the U.S.)—a date associated with cannabis culture that appears to drive cross-promotion of tobacco products—every year during the period of observation ( Figure 1 ).
highly significantp < 0.0010.0× alphaqualifiedgold
On the second day after a 10-day session of electric shocks in Context 1, the context conditioning was observed as a highly significant difference of behavioral response amplitudes in two contexts in all groups (panel “after learning”, Figure 3B , p < 0.001 for all groups, Wilcoxon Signed Rank Test, z = 3.6 for G1, z = 3.9 for G2, z = 3.5 for G3).
a clear trendP < .0010.0× alphagold
In the KDM-BA population, survival analyses across different quartiles of TyG-related indices (TyG, TyG-BMI, and TyG-WHtR) revealed significant differences, with log-rank tests showing a clear trend of decreased survival in higher quartiles for both all-cause and CVD mortality ( P < .001 for all indices; Fig. 2 A–F).
highly significantP < 0.0010.0× alphaqualifiedgold
On intragroup comparison from baseline to 3 months in the test group, PD showed a statistically significant change with P = 0.002; CAL, TAG, VDR [ Figure 6 ], and GRW [ Figure 7 ] all showed highly significant changes with P < 0.001; WKT showed no significant change with P = 0.667; and postsurgical discomfort levels also showed a highly significant change with P < 0.001 [ Table 2 ].
showed a trendP < 0.0010.0× alpha
In combined analysis, the addition of trastuzumab to paclitaxel resulted in a significant improvement in DFS (HR 0.52, P < 0.001) and reduction of death by 39% (OS, HR 0.61, P < 0.001) compared to paclitaxel alone.[ 13 ] The efficacy of concurrent versus sequential administration of trastuzumab showed a trend toward improvement in DFS in the concurrent arm; however, sequential was still better than placebo ( P < 0.001).